You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 24, 2025

Details for Patent: 10,507,295


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,507,295 protect, and when does it expire?

Patent 10,507,295 protects TRUDHESA and is included in one NDA.

This patent has eighteen patent family members in eight countries.

Summary for Patent: 10,507,295
Title:Nasal drug delivery device
Abstract: A compound delivery device for delivering a plume derived from a propellant and a drug formulation. The drug formulation is in an intranasal dosage form in the form of powder, suspension, dispersion or liquid. The propelled intranasal dosage form is deposited within the olfactory region of the nasal cavity. The drug deposited within the olfactory region is delivered to the brain avoiding the blood-brain-barrier. Hydrofluoroalkane propellant from a pressurized canister is channeled to a diffuser and drug-containing chamber where the intra-nasal dosage form is aerosolized. The aerosolized intra-nasal dosage form passes through a nozzle thus delivering a plume to the olfactory region of a user's nasal cavity.
Inventor(s): Hoekman; John D. (Seattle, WA), Hite; Michael (Normandy Park, WA), Brunelle; Alan (Woodinville, WA), Relethford; Joel (Everett, WA), Ho; Rodney J. Y. (Mercer Island, WA)
Assignee: Impel Neuropharma, Inc. (Seattle, WA)
Application Number:15/338,097
Patent Claim Types:
see list of patent claims
Compound; Delivery; Device; Dosage form;
Patent landscape, scope, and claims:

United States Patent 10,507,295: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 10,507,295, titled "Nasal drug delivery device," is a significant innovation in the field of pharmaceutical delivery systems. This patent, granted to its inventors, outlines a novel method and device for delivering drugs intranasally. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Number and Authority

The patent number is US10507295B2, and it was granted by the United States Patent and Trademark Office (USPTO)[4].

Prior Art and Background

The invention builds upon existing technologies in drug delivery, particularly those involving nasal administration. The prior art section of the patent highlights various earlier inventions related to nasal drug delivery devices, diffusers, and propellants, indicating the evolutionary nature of this technology[4].

Scope of the Invention

General Description

The patent describes a compound delivery device designed to deliver a plume derived from a propellant and a drug formulation in an intranasal dosage form. This device is engineered to optimize the delivery of therapeutic agents directly into the nasal cavity, enhancing efficacy and patient compliance[4].

Key Components

  • Propellant and Drug Formulation: The device uses a propellant to generate a plume that carries the drug formulation into the nasal cavity.
  • Diffuser: The invention includes a diffuser that helps in dispersing the drug formulation evenly.
  • Chamber: The device has a chamber where the propellant and drug formulation are housed before delivery[4].

Claims

Independent and Dependent Claims

The patent includes several claims that define the scope of the invention. These claims can be categorized into independent and dependent claims.

  • Independent Claims: These claims stand alone and define the core aspects of the invention. For example, Claim 1 describes the overall device and its components, including the propellant, drug formulation, and diffuser[4].
  • Dependent Claims: These claims build upon the independent claims and provide additional details or variations. For instance, dependent claims might specify particular materials for the diffuser or additional features of the chamber[4].

Claim Examples

  • Claim 1: A compound delivery device comprising a propellant, a drug formulation, and a diffuser to deliver the drug formulation in an intranasal dosage form.
  • Dependent Claim: The device of Claim 1, wherein the diffuser is made of a specific material to enhance dispersion[4].

Patent Landscape

Related Patents and Applications

The patent landscape for nasal drug delivery devices is extensive and includes various patents and applications from different inventors and companies. For example, the World Intellectual Property Organization (WIPO) and the European Patent Office (EPO) have similar patents and applications related to intranasal drug delivery systems[1].

Global Dossier and International Patent Offices

The Global Dossier service provided by the USPTO allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This service is crucial for understanding the global patent landscape and identifying potential prior art or conflicting patents[1].

Common Citation Document (CCD)

The Common Citation Document (CCD) application consolidates prior art cited by all participating offices for the family members of a patent application. This tool helps in visualizing the search results for the same invention produced by several offices on a single page, which is essential for navigating the complex patent landscape[1].

Economic and Market Impact

Market Demand

The demand for innovative drug delivery systems, particularly those targeting the nasal cavity, is increasing due to their potential for improved efficacy and patient compliance. This patent could play a significant role in meeting this demand and potentially disrupting the market with its novel approach[3].

Competitive Analysis

The competitive landscape includes other companies and inventors working on similar technologies. Analyzing the claims and scope of these patents can help in identifying unique selling points and potential areas for differentiation.

Legal and Regulatory Considerations

Patent Validity and Enforcement

The legal status of the patent is active, but it is important to note that the legal status listed is an assumption and not a legal conclusion. Ensuring the patent's validity and enforcing it against potential infringers are critical steps in protecting the intellectual property[4].

Office Actions and Examinations

The Patent Examination Data System (PEDS) and the Global Dossier can provide insights into office actions and examinations related to this patent. These tools help in understanding the scrutiny the patent underwent during the examination process and any potential challenges it may face in the future[1].

Key Takeaways

  • Innovative Design: The patent introduces a novel nasal drug delivery device with a propellant and diffuser system.
  • Extensive Claims: The patent includes multiple independent and dependent claims that define the scope of the invention.
  • Global Patent Landscape: The invention is part of a broader global patent landscape involving similar technologies from various IP Offices.
  • Market Potential: The patent has significant market potential due to the growing demand for innovative drug delivery systems.
  • Legal and Regulatory: Ensuring patent validity and enforcement is crucial, and tools like PEDS and Global Dossier are essential for navigating the legal landscape.

FAQs

What is the main purpose of the nasal drug delivery device described in US Patent 10,507,295?

The main purpose is to deliver a drug formulation in an intranasal dosage form using a propellant and a diffuser.

How does the diffuser in the device enhance drug delivery?

The diffuser helps in dispersing the drug formulation evenly within the nasal cavity, enhancing the efficacy of the drug delivery.

What are the key components of the nasal drug delivery device?

The key components include a propellant, a drug formulation, and a diffuser housed within a chamber.

How can one search for related patents and applications globally?

Using services like the Global Dossier and the Common Citation Document (CCD) can help in identifying related patents and applications filed at various IP Offices.

What is the significance of the Patent Examination Data System (PEDS) in relation to this patent?

PEDS allows users to search, view, and download bibliographic data for publicly available patent applications, including office actions and examinations related to this patent.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US10507295B2: https://patents.google.com/patent/US10507295B2/en

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,507,295

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Impel Pharms TRUDHESA dihydroergotamine mesylate SPRAY, METERED;NASAL 213436-001 Sep 2, 2021 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,507,295

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2012223160 ⤷  Try for Free
Australia 2016256665 ⤷  Try for Free
Australia 2018256518 ⤷  Try for Free
Brazil 112013022249 ⤷  Try for Free
Brazil 122021002471 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.